Valdemarsson S, Hansson P, Hedner P, Nilsson-Ehle P
Acta Endocrinol (Copenh). 1983 Sep;104(1):50-6. doi: 10.1530/acta.0.1040050.
Lipoprotein concentrations and activities of lipoprotein lipase (LPL) and hepatic lipase (HL) were measured in 70 subjects with thyroid function ranging from overt hypothyroidism over subclinical hypothyroidism and euthyroidism to hyperthyroidism. In parallel with serum T3 (S-T3) concentrations increasing from low in hypothyroidism to high in hyperthyroidism there were gradually higher HL activities over the full spectrum of thyroid function, accompanied by decreasing levels of total and low density lipoprotein (LDL) cholesterol. High density lipoprotein (HDL) cholesterol was lower (P less than 0.05) in hyperthyroidism than in euthyroidism but not significantly changed in the hypothyroid groups. HL was correlated to S-T3 (r = 0.77, P less than 0.001), LDL cholesterol to log S-T3 (r = -0.76, P less than 0.001), and LDL cholesterol to log HL (r = -0.55, P less than 0.001). The activity of LPL was decreased (P less than 0.001) in overt hypothyroidism compared to euthyroidism but, in contrast to HL, the activity of LPL was not increased in hyperthyroidism. The plasma triglyceride (P-TG) concentration was elevated (P less than 0.01) in overt hypothyroidism but not significantly changed in subclinical hypothyroidism or in hyperthyroidism. The LPL activity was correlated to log S-T3 (r = 0.45, P less than 0.001), P-TG to log S-T3 (r = -0.37, P less than 0.01) and P-TG to log LPL activity (r = -0.71, P less than 0.001). Our results demonstrate that thyroid hormones influence HL and LPL activities in different ways, suggesting different mechanisms of action. Changes in HL activity seem to be an important mechanism for the disturbance of cholesterol metabolism in thyroid dysfunction while the thyroid hormone influence on LPL seems to be of importance mainly for the disturbance in triglyceride metabolism.
对70名甲状腺功能从显性甲状腺功能减退、亚临床甲状腺功能减退、甲状腺功能正常到甲状腺功能亢进不等的受试者,检测了脂蛋白浓度以及脂蛋白脂肪酶(LPL)和肝脂肪酶(HL)的活性。随着血清T3(S-T3)浓度从甲状腺功能减退时的低水平逐渐升高至甲状腺功能亢进时的高水平,在整个甲状腺功能范围内HL活性逐渐升高,同时总胆固醇和低密度脂蛋白(LDL)胆固醇水平降低。甲状腺功能亢进时高密度脂蛋白(HDL)胆固醇低于甲状腺功能正常时(P<0.05),但在甲状腺功能减退组中无显著变化。HL与S-T3相关(r=0.77,P<0.001),LDL胆固醇与log S-T3相关(r=-0.76,P<0.001),LDL胆固醇与log HL相关(r=-0.55,P<0.001)。与甲状腺功能正常相比,显性甲状腺功能减退时LPL活性降低(P<0.001),但与HL不同,甲状腺功能亢进时LPL活性并未升高。显性甲状腺功能减退时血浆甘油三酯(P-TG)浓度升高(P<0.01),但亚临床甲状腺功能减退或甲状腺功能亢进时无显著变化。LPL活性与log S-T3相关(r=0.45,P<0.001),P-TG与log S-T3相关(r=-0.37,P<0.01),P-TG与log LPL活性相关(r=-0.71,P<0.001)。我们的结果表明,甲状腺激素以不同方式影响HL和LPL活性,提示不同的作用机制。HL活性的变化似乎是甲状腺功能障碍时胆固醇代谢紊乱的重要机制,而甲状腺激素对LPL的影响似乎主要对甘油三酯代谢紊乱起重要作用。